DK1012293T3 - Forbindelser til immunterapi og diagnose af tuberkulose og fremgangsmåder til deres anvendelse - Google Patents

Forbindelser til immunterapi og diagnose af tuberkulose og fremgangsmåder til deres anvendelse

Info

Publication number
DK1012293T3
DK1012293T3 DK98924827T DK98924827T DK1012293T3 DK 1012293 T3 DK1012293 T3 DK 1012293T3 DK 98924827 T DK98924827 T DK 98924827T DK 98924827 T DK98924827 T DK 98924827T DK 1012293 T3 DK1012293 T3 DK 1012293T3
Authority
DK
Denmark
Prior art keywords
sequences
polypeptide
antigen
dna
given
Prior art date
Application number
DK98924827T
Other languages
English (en)
Inventor
Yasir A W Skeiky
Antonio Campos-Neto
Mark R Alderson
Davin C Dillon
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of DK1012293T3 publication Critical patent/DK1012293T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98924827T 1997-05-20 1998-05-20 Forbindelser til immunterapi og diagnose af tuberkulose og fremgangsmåder til deres anvendelse DK1012293T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85938197A 1997-05-20 1997-05-20
US09/073,010 US6613881B1 (en) 1997-05-20 1998-05-05 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
PCT/US1998/010407 WO1998053075A2 (en) 1997-05-20 1998-05-20 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use

Publications (1)

Publication Number Publication Date
DK1012293T3 true DK1012293T3 (da) 2009-05-04

Family

ID=26754016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924827T DK1012293T3 (da) 1997-05-20 1998-05-20 Forbindelser til immunterapi og diagnose af tuberkulose og fremgangsmåder til deres anvendelse

Country Status (20)

Country Link
US (1) US6613881B1 (da)
EP (4) EP2270170B1 (da)
JP (4) JP4162155B2 (da)
KR (4) KR100909640B1 (da)
AT (1) ATE420180T1 (da)
AU (1) AU742751B2 (da)
BR (1) BR9809445A (da)
CA (2) CA2783134A1 (da)
CZ (2) CZ303194B6 (da)
DE (1) DE69840449D1 (da)
DK (1) DK1012293T3 (da)
ES (1) ES2321039T3 (da)
HU (1) HU226520B1 (da)
IL (2) IL133056A0 (da)
NO (4) NO324880B1 (da)
NZ (1) NZ501310A (da)
PL (1) PL191121B1 (da)
PT (1) PT1012293E (da)
TR (1) TR200000115T2 (da)
WO (1) WO1998053075A2 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP0986572B2 (en) * 1997-06-06 2007-06-13 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
CA2348475A1 (en) * 1998-11-04 2000-05-11 Isis Innovation Limited Tuberculosis diagnostic test
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
EP1200466A2 (en) * 1999-07-13 2002-05-02 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family
WO2001024820A1 (en) * 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
EP1278769A2 (en) * 2000-04-19 2003-01-29 Statens Serum Institut Tuberculosis antigens and methods of use thereof
ATE526994T1 (de) * 2000-06-20 2011-10-15 Corixa Corp Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
AU2003213118A1 (en) * 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
MX2007005256A (es) 2004-11-16 2008-03-11 Crucell Holland Bv Vacunas multivalentes que comprenden vectores virales recombinantes.
US8475803B2 (en) 2005-04-29 2013-07-02 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
EP1910410B1 (en) 2005-07-01 2011-10-26 Forsyth Dental Infirmary for Children Tuberculosis antigen detection assays and vaccines
US20070081944A1 (en) * 2005-09-30 2007-04-12 Reed Steven G Iontophoresis apparatus and method for the diagnosis of tuberculosis
EP2441469A1 (en) 2006-03-14 2012-04-18 Oregon Health and Science University Methods for producing an immune response to tuberculosis
ES2602430T3 (es) * 2008-07-25 2017-02-21 Glaxosmithkline Biologicals S.A. Polipéptidos, polinucleótidos y composiciones para uso en el tratamiento de tuberculosis latente
AU2009273133B2 (en) 2008-07-25 2014-06-05 Glaxo Group Limited Novel compositions and methods
EA201100070A1 (ru) 2008-07-25 2011-10-31 Глаксо Груп Лимитед Туберкулезный белок rv2386c, композиции и их применения
SI2528621T1 (sl) 2010-01-27 2017-01-31 Glaxosmithkline Biologicals S.A., Modificirani tuberkolozni antigeni
GB201012072D0 (en) * 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
RU2014101490A (ru) 2011-06-19 2015-07-27 Эйбоджен, Инк. Устройства, растворы и способы для сбора образцов
WO2016130543A1 (en) * 2015-02-09 2016-08-18 Abogen, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
NZ278270A (en) * 1993-12-23 1997-12-19 Pastoral Agric Res Inst Nz Ltd Mycobacteria virulence factor proteins and coding sequences and their use
IE960132A1 (en) * 1995-03-13 1996-09-18 Astra Ab New DNA molecules
ATE324445T1 (de) 1995-09-01 2006-05-15 Corixa Corp Verbindungen und verfahren zur diagnose von tuberkulose
CA2684425A1 (en) 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
JP2001500383A (ja) * 1996-10-11 2001-01-16 コリックサ コーポレーション 結核診断用の化合物および方法

Also Published As

Publication number Publication date
KR20010012812A (ko) 2001-02-26
KR20060066139A (ko) 2006-06-15
EP2270170B1 (en) 2013-11-06
US6613881B1 (en) 2003-09-02
KR20070026886A (ko) 2007-03-08
NO20075902L (no) 2000-01-18
PL337330A1 (en) 2000-08-14
JP4759010B2 (ja) 2011-08-31
NO20075901L (no) 2000-01-18
IL133056A (en) 2010-11-30
NO20075900L (no) 2000-01-18
NO324880B1 (no) 2007-12-27
DE69840449D1 (de) 2009-02-26
AU7690798A (en) 1998-12-11
HUP0003402A3 (en) 2001-03-28
EP2248900B1 (en) 2012-07-18
KR100909640B1 (ko) 2009-07-27
JP2008253260A (ja) 2008-10-23
HUP0003402A2 (hu) 2000-12-28
NZ501310A (en) 2001-09-28
JP2002514084A (ja) 2002-05-14
PT1012293E (pt) 2009-04-08
JP2008283961A (ja) 2008-11-27
JP4759011B2 (ja) 2011-08-31
WO1998053075A3 (en) 1999-04-01
ATE420180T1 (de) 2009-01-15
CZ303194B6 (cs) 2012-05-23
KR100893118B1 (ko) 2009-04-14
JP4162155B2 (ja) 2008-10-08
ES2321039T3 (es) 2009-06-01
CZ300866B6 (cs) 2009-08-26
KR100924475B1 (ko) 2009-11-03
PL191121B1 (pl) 2006-03-31
AU742751B2 (en) 2002-01-10
EP2248900A1 (en) 2010-11-10
WO1998053075A2 (en) 1998-11-26
JP4764445B2 (ja) 2011-09-07
IL133056A0 (en) 2001-03-19
EP2172551A3 (en) 2010-11-10
EP2172551A2 (en) 2010-04-07
EP2270170A1 (en) 2011-01-05
BR9809445A (pt) 2000-06-13
CA2783134A1 (en) 1998-11-26
KR20080036663A (ko) 2008-04-28
CZ410099A3 (cs) 2000-05-17
HU226520B1 (en) 2009-03-30
JP2008245644A (ja) 2008-10-16
KR100652513B1 (ko) 2006-12-01
NO995689D0 (no) 1999-11-19
EP1012293A2 (en) 2000-06-28
EP1012293B1 (en) 2009-01-07
TR200000115T2 (tr) 2000-11-21
CA2290774A1 (en) 1998-11-26
NO995689L (no) 2000-01-18

Similar Documents

Publication Publication Date Title
DK1012293T3 (da) Forbindelser til immunterapi og diagnose af tuberkulose og fremgangsmåder til deres anvendelse
WO1996040915A3 (en) Novel ctla4/cd28 ligands and uses therefor
WO2004076489A8 (en) Modified antibody
CA2281952A1 (en) Compounds for immunotherapy of prostate cancer and methods for their use
KR960704038A (ko) 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek)
WO1999055868A3 (en) Fizz proteins
CA2383424A1 (en) Novel b7-4 molecules and uses therefor
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
SE9402089D0 (sv) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
DK0531300T3 (da) Variant-CD44-overfladeproteiner, DNA-sekvenser, som koder herfor, antistoffer mod disse proteiner samt deres anvendelse til diagnostik og terapi
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
CA2241786A1 (en) Novel amp activated protein kinase
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
BR0209854A (pt) Molécula de ácido nucléico recombinante, cassete de expressão, vetor, polipeptìdeo, composição de vacina, dispositivo de aceleração de partìcula, e, método para gerar uma resposta imune celular em um indivìduo
DE60033583D1 (de) Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
WO2001036476A3 (en) Ing2, an iaps associated cell cycle protein, compositions and methods of use
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
NZ333988A (en) isolated DNA molecule encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof having a molecular weight of 45 to 60 kDa
NO20006456L (no) En mutant human hepatitt B viral stamme og anvendelser derav
HUP9903876A2 (hu) Eljárás és anyagok a tuberkulózis diagnosztizálására
NZ511303A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same with homology to Hep27 protein